104 records matched your query
03101aam a2200397 a 4500 001 2127349E517511E0A5987EABC41A358D 003 SILO 005 20110318103249 008 101101s2010 sz a 000 0 eng d 020 $a 9241548061 (in spiraalband) 020 $a 9789241548069 (in spiraalband) 035 $a (OCoLC)676636618 040 $a NLGGC $b dut $c NLGGC $e fobidrtb $d SILO $d TPH $d SILO 050 14 $a RA790.5 $b .M474 2010 110 2 $a Mental Health Gap Action Programme. 245 1 $a mhGAP intervention guide for mental, neurological and substance use disorders in non-specialized health settings : $b version 1.0 / $c Mental Health Gap Action Programme, World Health Organization. 246 3 $a Mental Health Gap Action Programme intervention guide 246 3 $a mhGAP intervention guide 246 3 $a mhGAP-IG 260 $a Geneva : $b World Health Organization, $c c2010. 300 $a vii, 83 p. : $b ill. ; $c 30 cm. 505 0 $a General principles of care -- Master chart -- Modules -- Moderate-severe depression -- Psychosis -- Bipolar disorder -- Epilepsy / seizures -- Developmental disorders -- Behavioural disorders -- Dementia -- Alcohol use and alcohol use disorders -- Drug use and drug use disorders -- Self-harm : suicide -- Other significant emotional or medically unexplained complaints -- Advanced psychosocial interventions 520 $a "The mhGAP-IG has been developed through an intensive process of evidence review. Systematic reviews were conducted to develop evidence-based recommendations. The process involved a WHO Guideline Development Group of international experts, who collaborated closely with the WHO Secretariat. The recommendations were then converted into clearly presented stepwise interventions, again with the collaboration of an international group of experts. The mhGAP-IG was then circulated among a wider range of reviewers across the world to include all the diverse contributions. The mhGAP-IG is based on the mhGAP Guidelines on interventions for mental, neurological and substance use disorders (http:// www.who.int/mental_health/mhgap/evidence/en/). The mhGAP Guidelines and the mhGAP-IG will be reviewed and updated in 5 years. Any revision and update before that will be made to the online version of the document. The mhGAP-IG has been developed for use in non-specialized health-care settings. 530 $a Also available via the World Wide Web as an Acrobat .pdf file (2.8 MB, 107 p.). 650 12 $a Mental Disorders $x prevention & control. $2 [MeSH] 650 12 $a Nervous System Diseases $x prevention & control. $2 [MeSH] 650 12 $a Psychotic Disorders $x prevention & control. $2 [MeSH] 650 12 $a Substance-Related Disorders $x prevention & control. $2 [MeSH] 650 0 $a Mental illness $x Prevention. 650 0 $a Substance abuse. 655 2 $a Guideline. $2 [MeSH] 710 2 $a World Health Organization. 856 41 $u http://whqlibdoc.who.int/publications/2010/9789241548069_eng.pdf 941 $a 1 952 $l OVUX522 $d 20180126015621.0 956 $a http://locator.silo.lib.ia.us/search.cgi?index_0=id&term_0=2127349E517511E0A5987EABC41A358DInitiate Another SILO Locator Search